Diallyl phthalate: Target Organs and Levels of Evidence for TR-242
Carcinogenesis Bioassay of Diallyl Phthalate (CASRN 131-17-9) in B6C3F1 Mice (Gavage Study)
Chemical (Study Title) CASRN |
Peer Review Date | Route/Exposure Levels | Study Laboratory |
---|---|---|---|
Diallyl phthalate 131-17-9 |
06/16/1982 | Gavage 0,150,300 MG/KG/50 PER GROUP |
Litton Bionetics, Inc. |
Levels of Evidence
Male Mice: Equivocal
Type | Organ/Tissue (Lesion) |
---|---|
Neoplastic Lesions |
|
Non-Neoplastic Lesions |
|
Female Mice: Equivocal
Type | Organ/Tissue (Lesion) |
---|---|
Neoplastic Lesions |
|
Non-Neoplastic Lesions |
|